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Abstract
Objective—The role of leptin in mesolimbic signaling non-food-related reward has been well 
established at the pre-clinical level, yet studies in humans are lacking. The present investigation 
explored the association between hedonic capacity and leptin dynamics, and whether this 
association differed by BMI class.
Methods—In this cross-sectional study of 75 women (42 with lean BMIs, 33 with obese BMIs), 
we measured serum leptin before/after meal consumption. Reward capacity was assessed using the 
Snaith-Hamilton Pleasure Scale (SHAPS). Multiple regression tested whether reward capacity was 
associated with leptin AUC, with an interaction term to test differences between lean (LN) and 
obese (OB) groups.
Results—The interaction of SHAPS by BMI group was robust (β=−.40, p=.005); among women 
with obesity, greater SHAPS score was associated with lower leptin AUC (β=−.35, p=.002, 
adjusted R-squared=.66). Among the lean group, the association was not statistically significant 
(β=−.16, p=.252, adjusted R-squared=.22). Findings were above and beyond BMI and age.
Conclusions—In this sample a robust, negative association between reward capacity and 
circulating leptin was stronger in women with obesity compared to lean counterparts. These 
findings suggest that despite likely leptin resistance, inhibitory leptin functioning related to non-
food reward may be spared in women with obesity.
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Introduction
Eating motivated by pleasure has distinct affective, behavioral, and clinical correlates 
compared to eating motivated by other factors, such as for coping with negative affect (1). 
By some accounts, differences in food-related pleasure thresholds between people with and 
without obesity may contribute to differences in food consumption (2). One underlying 
mechanism may be that people with obesity—compared to their leaner counterparts—
experience blunted pleasure, and are less sated by comparable food consumption.
The neurobiological mechanisms supporting these divergent phenotypes include an number 
of hormone, cytokine, and peptide systems involved in appetite (e.g., leptin, ghrelin, orexins, 
insulin) that are sensitive to the reward value of a given food (3). Emerging evidence 
indicates a distinct inhibitory role of leptin, an adipocytokine, on reward signaling in 
mesolimbic regions, facilitated in part through expression of leptin receptors on 
dopaminergic (DA) neurons in the ventral tegmental area (VTA) (4). Pre-clinical studies 
report reduced dopaminergic (DA) neuron firing following peripheral leptin administration 
(4) and that leptin attenuates DA activity in response to food cues which is reversed by 
peripheral leptin pre-treatment (5). People with obesity who also have genetic leptin 
deficiency exhibit elevated ventral striatal activity in response to food cues which is 
normalized by leptin treatment (6). These findings indicate that leptin plays a role in 
inhibiting DA-modulated signaling in reward regions, and thus could be involved in reward 
processing at a broader level than food. However, to our knowledge, evidence for the 
association between general hedonic capacity and leptin, and the extent to which these 
factors might be divergently related according to BMI class, has not been reported.
The current study was designed to examine the association between self-reported (non-food-
related) hedonic capacity and peripheral leptin dynamics in women characterized as with 
obesity or without (i.e., lean). We hypothesized that in light of leptin’s inhibitory effect on 
reward signaling, ratings of reward capacity would be inversely associated with changes in 
leptin following a meal. Furthermore, considering evidence suggesting unique coupling 
between peripheral leptin and mesolimbic reward activity in people with obesity (7), we 
expected that this association would be stronger and potentially restricted to women with 
BMIs in the obese range.
Methods
We studied 75 women between 21 and 43 years of age: 42 in the lean BMI range (LN group; 
BMI: M=22.3 kg/m2, SD=1.75; age: M=27.6, SD=3.41) and 33 in the obese range (OB 
group; BMI: M=37.9 kg/m2, SD=5.87; age: M=31.3; SD=6.30), recruited from the Boston, 
Massachusetts area through advertisements. Exclusion criteria included current pregnancy or 
breastfeeding, neurological disease, diabetes, endocrine disorders, current major psychiatric 
disorders, significant change in weight within the last three months, current use of 
glucocorticoids, steroids, neuroleptics or stimulants. All participants provided written 
informed consent. All study procedures were approved by the Partners Healthcare Human 
Research Committee.
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Following a screening visit at the Brigham and Women’s Hospital Center for Clinical 
Investigation to ascertain height, weight, and other clinical variables, eligible participants 
were brought in for a main study visit during the follicular phase (days 1–10) of their 
menstrual cycle; participants (n=11 LN; n=7 OB) on oral contraceptives completed study 
procedures during the inactive (placebo) week of their regimen. On the morning of the visit, 
following an overnight (12 hr) fast, a saline-lock IV line was placed in the participant’s non-
dominant arm to enable serial blood draws. Participants completed other study procedures 
(not relevant to the current study), then were asked to consume a standardized meal, 
preceded and followed by blood draws. The meal contained 30% of the recommended daily 
caloric intake (varying according to each participant’s basal metabolic rate/activity level, 
measured by the Harris-Benedict equation; with 18% calories from protein, 23% calories 
from fat, and 59% calories from carbohydrates). Blood samples were ascertained 
immediately prior to the meal (Time 0; T0), and 30 (T30), 60 (T60), and 120 (T120) minutes 
following meal commencement.
Following the meal, participants completed the Snaith-Hamilton Pleasure Scale (SHAPS) 
(8), a 14-item questionnaire measuring degree of pleasure experienced by the individual in 
the recent days on a 4–point Likert-type scale. Item examples include: “I would find 
pleasure in my hobbies and pastimes,” “I would be able to enjoy a beautiful landscape or 
view,” and “I would enjoy seeing other people’s smiling faces.” The alpha for the scale in 
this sample was .87. To reduce the possibility that associations with leptin AUC would be 
driven solely by food-related items, the three with food-, olfactory-, or gustatory-related 
content (“I would be able to enjoy my favorite meal,” “I would find pleasure in the scent of 
flowers or the smell of a fresh sea breeze or freshly baked bread,” and “I would enjoy a cup 
of tea or coffee or my favorite drink”) were deleted. The reliability of this amended scale 
was .85, demonstrating strong construct validity. Thus we used the 11-item version to reduce 
the chance that potential associations would be driven by the food-related items. To capture 
the broadest extent of variability in responses, scores were calculated by summing the 
individual item responses (rather than the dichotomous scoring traditionally used for the 
SHAPS) and dividing by the number of items, yielding a minimum score of 1.0 (indicating 
low reward capacity) and a maximum of 4.0 (indicating high reward capacity), an approach 
used previously in assessing reward capacity in clinical and non-clinical populations (9).
Approximately 10–15 cc of blood was sampled at each time point, allowed to clot for 45–60 
min, spun, aliquoted, and stored frozen at −80°C. Serum leptin was analyzed in duplicate 
with a commercial radioimmunoassay kit (LINCO Research, St. Charles, MS; inter-assay 
CV: 3.2–8.9%; intra-assay CV: 5.2–7.5%). Area under the curve for leptin was calculated 
using the trapezoidal method.
We computed means, standard deviations, skew, and kurtosis by BMI group (i.e., LN and 
OB). Differences between LN and OB groups on demographic (age, BMI, race/ethnicity, 
years of education) and primary variables of interest (SHAPS score, leptin AUC) were tested 
using Pearson Χ2 or independent samples t-tests. Effect size differences between groups 
were estimated using Hedges’ g (10), which is a less biased estimator than Cohen’s d when
—as is the current sample—sample sizes of groups are unequal, relatively small, and 
standard deviations between the group differ (11). Given age differences by BMI group, age 
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was retained as covariate in multivariate models. To minimize residual confounding, we 
included continuous BMI as an additional covariate. We inspected correlations among the 
study variables for LN and OB groups. Multiple regression modeling tested whether reward 
capacity (operationalized as the mean score on the SHAPS questionnaire) was associated 
with metabolic hormone dynamics (leptin AUC). The interaction term of reward capacity 
multiplied by BMI group tested whether the association was different for LN v. OB groups. 
We reported confidence intervals and effect size estimates (12). Data were analyzed using 
SPSS 23 (IBM Corp., Armonk, NY).
Results
Women in the lean v. obese range had lower BMIs and were slightly younger (see Table 1). 
Groups did not differ significantly (p<.05) on race (LN: 78.6% White, 7.1% Black, 9.6% 
Asian, 4.8% other; OB: 78.8% White, 12.1% Black, 3.0% Asian, 6.1% other), ethnicity (LN: 
88.1% non-Hispanic; 11.9% Hispanic; OB: 93.9% non-Hispanic, 6.1% Hispanic), or 
educational attainment (LN: Less than an Associate degree, 4.8%, Associate degree or more, 
95.1%; OB: Less than an Associate degree or less, 15.6%, Associate degree or more, 
84.4%). There was no difference between groups in the proportion of women using 
hormonal contraceptives (LN: 11 out of 42; OB: 7 out of 33; Χ2=.25, p=.62).
Leptin and BMI were positively correlated, more strongly so for OB (r=.75, p<.001) than 
LN (r=.50, p=.001). LN and OB groups did not differ on levels of reward capacity, but did 
differ in the associations of reward capacity with leptin AUC. Among the LN group, reward 
capacity was not statistically significantly associated with leptin AUC (r=−.15, p=.33). For 
women with obesity, higher reward capacity was correlated with lower leptin AUC (r=−.38, 
p=.03) in the laboratory task. Age was not correlated with any of the other variables in this 
sample for LN or OB groups.
The interaction of SHAPS by BMI group was robust (β=−.40, B=−2352, SE=805, p=.005, 
CI [−3959, −746]); among women with obesity, greater SHAPS score was associated with 
lower leptin AUC; among lean women, there was no statistically significant association. 
Findings were above and beyond BMI and age. Table 2 presents regression analyses 
stratified by BMI group. The key finding is that among women with obesity, greater reward 
capacity was associated with lower leptin AUC; this association did not hold among lean 
women (see Figure 1).
Discussion
In the present study, we demonstrate a novel association between leptin dynamics and 
general reward capacity in women, and provide preliminary evidence that this association is 
unique to women with BMIs in the obese range. Reward capacity was significantly 
associated with leptin changes in response to a meal in women with obesity, but not in lean 
women. This association remained robust in the group of women with obesity even after 
accounting for BMI and age. To our knowledge, these findings are the first to suggest that 
the inhibitory effect of leptin on reward processing in humans may extend beyond food-
related hedonic experience to encompass pleasure associated with everyday situations.
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Recent pre-clinical reports provide emerging mechanistic evidence for the role of leptin in 
reward functioning beyond food-related hedonic capacity. Central or peripheral leptin 
administration significantly attenuates cocaine-mediated reward processing (13), while 
obese, leptin-deficient ob/ob mice exhibit abnormal responses to standard reward tasks and 
to drugs of abuse (cocaine, opioids, and ethanol) compared to wild-type mice (14), 
suggesting leptin’s blunting of reward capacity may extend to non-food substances and other 
primary rewards. The extent to which these functions systematically differ according to fat 
mass have not been well-explored in humans. Although leptin resistance (the inability of 
leptin to inhibit food intake and stimulate energy expenditure, despite elevated levels) is 
commonly manifested in obesity, the mechanisms of leptin resistance and specificity to 
various CNS targets remain to be fully elucidated. For example, exogenous vs. endogenous 
leptin appear to produce differential leptin resistance (15), a phenomenon which may be 
further promoted or inhibited by exposure to various dietary conditions (high-fat, low-fat, 
chow, etc.) (16). Further, some aspects of leptin action appear uniquely spared, including 
cardiovascular sympathetic effects (17, 18), possibly due to selective resistance to leptin in 
particular cell types, cellular and molecular signaling cascades following leptin receptor 
(LepR) binding, differential action on certain brain regions (19), altered free:bound leptin in 
circulation in obesity (20) resulting in differential desensitization, and reduced leptin 
transport across the blood brain barrier in obesity (21) [for a recent full review, see (22)]. 
Among the contributing factors to differential or selective leptin resistance which lend 
insight into the current data, recent evidence suggests that although diet-induced obesity 
(DIO) in rats is associated with leptin resistance as quantified by unchanged mRNA 
expression of POMC and NPY in the arcuate nucleus following ICV leptin administration, 
mesolimbic brain regions (including the VTA and NAcc) remain sensitive to leptin in DIO, 
but not in lean rats (23). These results suggest the intriguing possibility that leptin-induced 
food-related reward signaling is intact in DIO, although generalization of these findings 
beyond food-related appetite and reward in rodent models remain to be elucidated.
In line with these basic data, current findings demonstrating that our sample of women with 
obesity exhibited the expected inverse relationship between leptin AUC and reward capacity 
suggest that leptin inhibition of non-food rewards may be selectively spared, although with 
potentially negative implications for this population. Further studies on the mechanism 
behind the interactions between fat mass, peripheral leptin levels, and reward capacity, and 
the degree to which this impacts general well-being in individuals with obesity would assist 
in elucidating the complex systemic effects of leptin in humans. Additionally, given the 
complex role of catecholamines, such as dopamine, in immune responses (24), and recent 
data suggesting that obesity may be characterized by neuroinflammation (15, 16), 
investigation of the interactions between leptin, dopamine signaling, and peripheral and 
central inflammatory mediators would strengthen the understanding of the degree to which 
consumption of highly-rewarding, palatable diets (i.e., high-sugar, high-fat) predispose 
certain individuals to obesity, neuroinflammation in homeostatic and hedonic appetite 
circuitry, and impaired general reward capacity.
Major strengths of this study include a focus on the leptin-reward capacity association in 
human subjects; a well-controlled laboratory setting; and novel use of a well-validated 
assessment of reward capacity (SHAPS) to examine non-food reward in humans. We were 
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limited by a cross-sectional design, which prevents causal inferences, restriction to female 
participants, and reliance on BMI rather than a more precise measurement of fat and lean 
mass, which would be more closely linked to leptin levels. Additionally, as the SHAPS is a 
self-report questionnaire, it may represent a biased measure of reward capacity. However, 
because reward capacity is a subjective phenomenon, starting with a self-report measure is a 
sensible choice. Future research could benefit from including an implicit measure of reward 
capacity. We also acknowledge that other factors, including but not limited to genetics, 
neural circuitry sensitivity to various non-food rewards, recent exercise, and current mood, 
for example, may influence non-food reward capacity. As these were not addressed in the 
current study, we cannot exclude these as potential confounders.
In conclusion, here we report for the first time a robust inverse relationship between hedonic 
capacity and leptin dynamics in women with BMIs in the obese range. In addition to testing 
for replication, future studies may benefit from utilizing longitudinal designs, including male 
participants to explore sex and gender differences, employing other measures of general 
hedonic capacity (e.g., more objective or more implicit), objectively measuring fat and lean 
mass, and exploring potential mediators of the identified effects. Finally, given the social and 
clinical implications of these findings—suggesting individuals with obesity who exhibit 
elevated leptin are vulnerable to reduced ability to experience pleasure—once confirmed in 
other samples, additional investigations focused on leptin-based therapies and their effects 
on reward capacity in individuals with obesity are needed to mitigate the potential harmful 
long-term consequences of reduced reward capacity on overall well-being and quality of life.
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Acronyms
BMI body mass index
LN lean
OB obese
SHAPS Snaith-Hamilton Pleasure Scale
AUC area under the curve
DA dopamine
VTA ventral tegmental area
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Study Importance Questions
1) What is already known about this subject?
• Leptin decreases food intake in animal models and in humans, partially 
through influencing reward processing around food.
• Pre-clinical data suggest leptin inhibits dopamine signaling and may influence 
non-food reward.
• Similar studies in humans, linking leptin and non-food reward, have not been 
reported.
2) What does your study add?
• Regression modeling shows statistically significant inverse associations 
between general reward capacity and postprandial leptin.
• This relationship was specific to women with BMIs in the obese range.
• Leptin inhibition may extend beyond food-related hedonic experience to 
encompass pleasure associated with other daily associations.
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Figure 1. Effect of Reward Capacity on Leptin AUC is Modified by BMI Group
Scatterplot demonstrating the relationship between postprandial serum leptin levels (Leptin 
AUC) and SHAPS score (Reward Capacity), with data markers and fit lines stratified by 
group according to the legend.
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